Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
285.00    10.00 (3.64%)
Bid:
280.00
Ask:
290.00
Spread: 10.00 (3.571%)
Market Cap: £85.71m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Director/PDMR Shareholding

23 May 2025 11:38

RNS Number : 0090K
Mpac Group PLC
23 May 2025
 

23 May 2025

 

Mpac Group plc

("Mpac" or the "Company")

 

Grant of Options

 

Director/PDMR Dealing

 

Mpac Group plc, the global packaging and automation solutions Group, announces that, on 21 May 2025, it awarded a total of 171,548 options to subscribe for new shares of 25 pence each in the Company ("Ordinary Shares") under the Mpac Group plc Long Term Incentive Plan ("LTIP") to certain of the Company's Directors/PDMRs in the amounts set out below (the "LTIP Options"):

Director/PDMR

Number of LTIP Options

Adam Holland, CEO

119,247

William Wilkins, Group Finance Director

52,301

 

The LTIP Options are exercisable at the nominal price of £0.25 and have vesting conditions tied to cumulative Earnings Per Share (EPS) and average Operating Return On Sales (Operating ROS). Each award will vest based on 70% of EPS performance and 30% of Operating ROS performance. Cumulative EPS has to exceed 155p over the performance period to vest in full. Vesting is reduced to 40% on a pro-rata basis if cumulative EPS is 140p over the performance period and is reduced to nil if below 140p. Average Operating ROS has to exceed 10% to vest in full. Vesting is reduced to 40% on a pro-rata basis if average Operating ROS is 9% over the performance period and is reduced to nil if below 9%.

The performance period will be 1 January 2025 to 31 December 2027 and, to the extent vested, the options will be subject to a two-year holding period following the vesting of the award. However, shares may be sold to cover any tax liability arising from exercise during the two year holding period.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of a transaction by a person discharging managerial responsibilities ("PDMR").

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Holland

2

Reason for the notification

a)

Position/status

Chief Executive Officer / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

 119,247

d)

Aggregated information

- Volume 

- Price

- Total

N/A

e)

Date of the transaction

21 May 2025

f)

Place of the transaction

N/A

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

William Wilkins

2

Reason for the notification

a)

Position/status

Group Finance Director / PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Options over ordinary shares exercisable at £0.25

GB0005991111

b)

Nature of the transaction

Grant of options under the Mpac Group plc Long-Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

n/a

 52,301

d)

Aggregated information

- Volume 

- Price

- Total

N/A

e)

Date of the transaction

21 May 2025

f)

Place of the transaction

N/A

 

 

For further information please contact:

 

Mpac Group plc

Adam Holland, Chief Executive Officer

Will Wilkins, Chief Financial Officer

 

 

Tel: +44 (0)24 7642 1100

 

 

Shore Capital (Nomad and Joint Broker)

Advisory

Patrick Castle

Sophie Collins

 

Broking

Henry Willcocks

 

Tel: +44 (0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Freddie Wooding

 

 

Tel: +44 (0)20 3100 2000

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

 

Tel: +44 (0) 20 7796 4133

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAJMMTMTJTBFA
Date   Source Headline
15th Jul 201011:07 amRNSHolding(s) in Company
24th Jun 201010:36 amRNSHolding(s) in Company
22nd Jun 20107:00 amRNSInterim Management Statement
6th May 20109:45 amRNSDirector/PDMR Shareholding
4th May 20109:45 amRNSDoc re. Annual General Meeting
30th Apr 20102:38 pmRNSInterim Management Statement
25th Mar 20105:37 pmRNSHolding(s) in Company
2nd Mar 20104:01 pmRNSDirector/PDMR Shareholding
1st Mar 20105:25 pmRNSDirector/PDMR Shareholding
26th Feb 20107:00 amRNSPreliminary Results
19th Feb 20107:00 amRNSNotice of Results
23rd Oct 20098:30 amRNSInterim Management Statement
28th Aug 20097:00 amRNSInterim Results
25th Aug 20097:00 amRNSNotification of Interim Results
27th Apr 200911:35 amRNSDoc re. Annual General Meeting Resolutions
24th Apr 20092:00 pmRNSInterim Management Statement
27th Feb 20094:21 pmRNSDirector/PDMR Shareholding
27th Feb 20097:00 amRNSFinal Results
19th Feb 200911:24 amRNSNotice of Results
26th Jan 20096:30 pmRNSHolding(s) in Company
8th Jan 20096:25 pmRNSHolding(s) in Company
5th Dec 200811:19 amRNSDirectorate Change
3rd Dec 20081:53 pmRNSSale of the Saunderton Property
1st Dec 200812:11 pmRNSHolding(s) in Company
7th Nov 200812:06 pmRNSHolding(s) in Company
17th Oct 200811:01 amRNSInterim Management Statement
6th Oct 20086:20 pmRNSHolding(s) in Company
15th Sep 20083:33 pmRNSHolding(s) in Company
28th Aug 20087:00 amRNS2008 HALF-YEAR ANNOUNCEMENT
18th Jun 20082:25 pmRNSBoard Changes
28th Apr 200811:09 amRNSDoc re. AGM
25th Apr 20081:54 pmRNSInterim Management Statement
4th Apr 20083:07 pmRNSHolding(s) in Company
19th Mar 200811:07 amRNSDoc re. AGM Result
18th Mar 20081:45 pmRNSResult of General Meeting
29th Feb 20082:06 pmRNSDirector/PDMR Shareholding
29th Feb 20087:02 amRNSGrant of a Call Option
29th Feb 20087:01 amRNSPreliminary Results
25th Jan 20089:59 amRNSDirectorate Change
23rd Jan 20086:23 pmRNSHolding(s) in Company
2nd Jan 20085:46 pmRNSHolding(s) in Company
2nd Jan 20085:03 pmRNSHolding(s) in Company
21st Nov 20077:00 amRNSHolding(s) in Company
25th Oct 20072:05 pmRNSBoard Change
21st Sep 20073:16 pmRNSHolding(s) in Company
18th Sep 20074:12 pmRNSHolding(s) in Company
7th Sep 20071:12 pmRNSHolding(s) in Company
31st Aug 20077:01 amRNSInterim Results
30th Aug 200712:17 pmRNSSale of Nottingham Site
9th Aug 20074:38 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.